IP Verse

Ucb Pharma Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Ucb Pharma Gmbh

Patent Number:
EP3345607
Title:
Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or Agonist
Applicant:
OSSIFI-MAB LLC
Opposition Date:
Jul 26, 2023

Latest patents of Ucb Pharma Gmbh opposed by its competitors

Patent:
EP3145504
Grant Date:
Jul 26, 2023
Title:
Transdermal Delivery System Including An Interface Mediator
Oppositions:
1
Patent:
EP2645997
Grant Date:
Aug 10, 2022
Title:
Once Daily Formulation Of Lacosamide
Oppositions:
1
Patent:
EP2992891
Grant Date:
Aug 5, 2020
Title:
Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant Effect
Oppositions:
1
Patent:
EP2515887
Grant Date:
Jun 6, 2018
Title:
Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine
Oppositions:
2
Patent:
EP2037965
Grant Date:
Aug 30, 2017
Title:
Pharmaceutical Composition With Synergistic Anticonvulsant Effect
Oppositions:
1
Patent:
EP2922533
Grant Date:
Jun 14, 2017
Title:
Multi-Day Patch For The Transdermal Administration Of Rotigotine
Oppositions:
2

Competitors of Ucb Pharma Gmbh

ACCORD HEALTHCARE LTD

AMW GMBH

FH SERVICES LIMITED

Want to track Ucb Pharma Gmbh?

Feel free to send us a message here and we will get back to you